Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways
Hongliang Li(Jiangnan University), Chih‐Chuan Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), Gregory M. Williams(Johns Hopkins University), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Huang(Chinese Academy of Medical Sciences & Peking Union Medical College), Guang Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Rui-Tai Hui(Chinese Academy of Medical Sciences & Peking Union Medical College), Chiming Wei(Nano-C (United States)), Yu-Qing Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ai-Bing Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chan-Na Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 136
Related Papers
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
|Cardiovascular Research|2008|388